Search for: "US Compounding Inc."
Results 181 - 200
of 1,415
Sorted by Relevance
|
Sort by Date
29 May 2011, 9:01 pm
Patent No. 5,587,497 ("19-nor-Vitamin D Compounds," issued December 24, 1996) following a Paragraph IV certification as part of Sandoz's filing of an ANDA to manufacture a generic version of Abbott's Zemplar® (paricalcitol, used to treat secondary hyperparathyroidism in patients with kidney failure). [read post]
11 Apr 2014, 10:41 am
©2014 Amaxx Risk Solutions, Inc. [read post]
8 Sep 2021, 7:50 am
In undoubtedly one of the most important decisions of the year so far, on 24 August 2021, the English Court of Appeal handed down its judgment in FibroGen v Akebia (FibroGen Inc v Akebia Therapeutics Inc [2021] EWCA Civ 1279), partially allowing FibroGen’s appeal, and so finding one of the ‘Family A’ patents, EP 823, valid and infringed. [read post]
13 Nov 2023, 9:43 am
OSRX, Inc., 2023 WL 7390842, No. 21-cv-01305-BAS-DDL (S.D. [read post]
24 Nov 2008, 2:09 am
Patent Nos. 5,246,925 ("19-nor-Vitamin D Compounds for Use in Treating Hyperparathyroidism," issued September 21, 1993) and 5,587,497 ("19-nor-Vitamin D Compounds," issued December 24, 1996) following a Paragraph IV certification as part of Teva's filing of an ANDA to manufacture a generic version of Abbott's Zemplar ® (paricalcitol, used to... [read post]
29 Sep 2008, 3:15 pm
Wishnie's The Story of Hoffman Plastic Compounds, Inc. v. [read post]
31 Dec 2007, 10:24 am
This is my list of the top ten based on the potential for near-term commercialization/value and claim breadth in light of the potential market.10) US Patent 7,195,754 (Eikos Inc.) [read post]
27 Sep 2019, 10:10 am
Last week, the government announced that compounding pharmacy Diabetic Care Rx LLC, known as Patient Care America (“PCA”), its executives, and the private equity firm managing the pharmacy Riordan, Lewis & Haden Inc., had agreed to pay over $21 million to settle allegations they violated the False Claims Act (“FCA”) by executing a kickback scheme to generate referrals of TRICARE patients. [read post]
10 Feb 2010, 6:29 pm
Those compounds are sold to Recticel Interiors N.A. for use in its products and to BASF SE for use as a basic material in the manufacture of car window encapsulations. [read post]
7 Jan 2007, 4:53 pm
The assignee is listed as Pure World Botanicals, Inc. [read post]
9 May 2012, 12:49 pm
" Hospira, Inc., et. al. v. [read post]
4 Oct 2019, 10:27 am
Apotex Inc. [read post]
16 May 2013, 3:23 am
In re Argo Tea, Inc., Serial No. 85011197 (May 9, 2013)[not precedential].The PTO must establish genericness by "clear evidence," the key issue being whether the relevant public primarily uses or understands the applied-for term to refer to the category or class of goods at issue. [read post]
16 Jun 2011, 2:04 am
"However, "a domain name is an address, and when used as a trademark is not a title. [read post]
26 Feb 2014, 5:37 pm
Procedural HistoryPlaintiff GlaxoSmithKline LLC (“GSK”) sued Banner Pharmacaps, Inc., Impax Laboratories, Inc., Roxane Laboratories, Inc., Mylan Inc., Mylan Pharmaceuticals, Inc., and Watson Laboratories, Inc. [read post]
13 Jul 2018, 5:54 pm
The outcome:Jazz Pharmaceuticals, Inc. [read post]
28 May 2013, 9:41 am
” CFMT, Inc. v. [read post]
4 Nov 2022, 8:24 am
Nestlé USA, Inc., --- F.Supp.3d ----, 2022 WL 4626916, No. 21-CV-7255 (RA) (S.D.N.Y. [read post]
21 Oct 2014, 9:03 am
Teva Pharmaceuticals USA, Inc., the Federal Circuit panel affirmed a lower court finding that BMS’s patent covering the Hep-B drug entecavir is invalid as obvious. [read post]
17 Mar 2022, 2:32 pm
In another case, we found a lack of written description when claims were directed to a method comprising administering a compound to achieve a particular result but the specification failed to disclose any compounds that could be used in the claimed method. [read post]
